GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pyridam Farma Tbk PT PYFA.JK · IDR

Health Care · IDX · 🇮🇩 Indonesia

Compare

118

0.00%

Close of 9 Nov 2026, in IDR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in IDR, from our data supplier.

FY2025

Revenue

IDR 2.76trn

FY2016FY2025

Net income

−IDR 379.67bn

FY2016FY2025

Free cash flow

−IDR 503.91bn

FY2016FY2025

Shareholders' equity

IDR 766.99bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueIDR 2.76trnIDR 1.92trnIDR 702.07bnIDR 715.42bnIDR 630.53bnIDR 277.40bnIDR 247.11bnIDR 250.45bnIDR 223.00bnIDR 216.95bn
Research and developmentIDR 21.54bnIDR 17.62bnIDR 17.77bnIDR 11.28bnIDR 573.4m—IDR 5.65bnIDR 853.2mIDR 2.31bnIDR 1.19bn
Operating income−IDR 164.10bn−IDR 116.35bnIDR 1.88bnIDR 345.86bnIDR 52.19bnIDR 32.14bnIDR 15.28bnIDR 14.51bnIDR 14.53bnIDR 13.99bn
Net income−IDR 379.67bn−IDR 330.25bn−IDR 85.22bnIDR 275.24bnIDR 5.48bnIDR 22.10bnIDR 9.34bnIDR 8.45bnIDR 7.13bnIDR 5.15bn
Diluted earnings per share-33.79-29.39-34.20514.3910.248.8717.463.162.661.92

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsIDR 6.77trnIDR 5.81trnIDR 1.52trnIDR 1.52trnIDR 806.22bnIDR 228.58bnIDR 190.79bnIDR 187.06bnIDR 159.56bnIDR 167.06bn
Cash and short-term investmentsIDR 101.79bnIDR 353.50bnIDR 89.97bnIDR 136.58bnIDR 47.73bnIDR 9.64bnIDR 5.29bnIDR 1.95bnIDR 379.6mIDR 1.37bn
Total liabilitiesIDR 5.79trnIDR 4.77trnIDR 1.16trnIDR 1.08trnIDR 639.12bnIDR 70.94bnIDR 66.06bnIDR 68.13bnIDR 50.71bnIDR 61.55bn
DebtIDR 4.84trnIDR 3.87trnIDR 986.99bnIDR 910.04bnIDR 448.81bnIDR 35.51bnIDR 19.41bnIDR 24.52bnIDR 10.27bnIDR 27.73bn
Shareholders' equityIDR 766.99bnIDR 1.04trnIDR 356.83bnIDR 442.13bnIDR 167.10bnIDR 157.63bnIDR 124.73bnIDR 118.93bnIDR 108.86bnIDR 105.51bn
Shares outstanding11,237m11,237m2,492m535m535m2,492m535m2,675m2,675m2,675m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−IDR 364.28bn−IDR 141.04bn−IDR 103.98bnIDR 275.24bnIDR 39.59bnIDR 1.11bnIDR 17.61bnIDR 1.76bnIDR 2.84bnIDR 2.83bn
Capital spending−IDR 139.62bn−IDR 135.22bn−IDR 23.66bn−IDR 46.47bn−IDR 222.03bn−IDR 7.84bn−IDR 3.27bn−IDR 20.48bn−IDR 3.32bn−IDR 2.60bn
Free cash flow−IDR 503.91bn−IDR 276.26bn−IDR 127.64bnIDR 228.77bn−IDR 182.45bn−IDR 6.72bnIDR 14.34bn−IDR 18.72bn−IDR 472.9mIDR 231.4m
Dividends paid—−IDR 31.63bn————−IDR 2.14bn−IDR 2.14bn−IDR 1.55bn−IDR 1.55bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueIDR 850.99bnIDR 766.53bnIDR 700.18bnIDR 674.84bnIDR 699.95bnIDR 685.46bnIDR 758.98bnIDR 754.51bn
Operating income−IDR 2.44bn−IDR 3.40bn−IDR 75.85bn−IDR 29.37bn−IDR 47.29bn−IDR 21.27bnIDR 5.93bnIDR 11.29bn
Net income−IDR 97.40bn−IDR 80.88bn−IDR 13.85bn−IDR 152.61bn−IDR 122.61bn−IDR 90.59bn−IDR 116.02bn−IDR 99.04bn
Diluted earnings per share-8.67-7.20-1.23-13.58-10.91-8.06-10.32-8.81
Cash from operations−IDR 125.07bn−IDR 192.32bn−IDR 28.54bn−IDR 81.08bn−IDR 155.84bn−IDR 98.83bn−IDR 155.10bn−IDR 137.81bn
Capital spending−IDR 22.63bn−IDR 14.92bn−IDR 30.96bn−IDR 69.55bn−IDR 2.51bn−IDR 57.71bn−IDR 102.61bn−IDR 19.50bn
Free cash flow−IDR 147.70bn−IDR 207.24bn−IDR 59.50bn−IDR 150.63bn−IDR 158.35bn−IDR 156.54bn−IDR 257.71bn−IDR 157.31bn
Total assetsIDR 7.39trnIDR 7.07trnIDR 6.77trnIDR 6.92trnIDR 6.85trnIDR 5.96trnIDR 5.81trnIDR 5.89trn
Cash and short-term investmentsIDR 127.11bnIDR 49.07bnIDR 101.79bnIDR 163.38bnIDR 266.60bnIDR 270.56bnIDR 353.50bnIDR 505.42bn
DebtIDR 1.06trnIDR 3.89trnIDR 4.92trnIDR 5.06trnIDR 4.92trnIDR 3.97trnIDR 3.87trnIDR 3.88trn
Shareholders' equityIDR 684.19bnIDR 719.41bnIDR 766.99bnIDR 732.88bnIDR 856.40bnIDR 972.28bnIDR 1.04trnIDR 1.20trn

Financial ratios

Data as of 26 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-5.9%-6.1%0.3%48.3%8.3%11.6%—
Net margin-13.8%-17.2%-12.1%38.5%0.9%8.0%—
Return on equity-49.5%-31.8%-23.9%62.3%3.3%14.0%—
Return on assets-5.6%-5.7%-5.6%18.1%0.7%9.7%—
Free cash flow yield-9.3%-0.2%-15.1%281.0%228.5%1.7%—
Revenue growth43.7%173.6%-1.9%13.5%127.3%12.3%—
Earnings growth15.0%287.5%-131.0%4923.6%-75.2%136.6%—
Current ratio1.24x1.28x1.94x1.82x1.30x2.89x—
Debt to equity4.83x3.36x2.75x2.04x2.63x0.20x—
Equity ratio11.3%17.9%23.5%29.1%20.7%69.0%—
Interest coverage-0.50x-0.51x0.02x3.98x1.24x12.53x—
R&D as a share of sales0.8%0.9%2.5%1.6%0.1%—2.3%
Buybacks as a share of market value-0.0%-350.9%-365.8%0.0%78.5%-365.8%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue56.8%58.3%28.9%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-6.0%1.1%2.2%2.7%
Net margin-15.2%-8.5%-7.0%-5.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-14.1-7.2-6.60.319.421.62.211.713.520.4
Price to sales1.91.20.80.10.21.70.10.40.40.5

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 31 May 2019.

FY2019FY2017FY2002
Paid in the year4.002.901.67
  • 1.029-for-1 split · 5 Nov 2002

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.